Partnerships
The VHL Alliance is partnering with The Mighty to increase awareness through The Mighty’s extensive and wide reaching readership.
The VHL Alliance welcomes you to share your story on the VHLA’s home page on The Mighty. The Mighty is a story-based health community focused on increasing the general population’s knowledge of VHL and how it plays a role in finding a cure for cancer.
We encourage you, as a patient or caregiver, to submit a story to The Mighty so your VHL story can be shared. If you have any questions, please contact the VHLA office.
The VHL Patient Natural History Study (also known as Cancer in Our Genes International Patient Databank – CGIP) is a collaboration between the VHL Alliance and the National Organization of Rare Disorders (NORD).
Don’t let your information be the missing piece. Register and participate in the Databank today!
PracticeUpdate and VHL Alliance recently partnered to create the Von Hippel-Lindau Disease Spotlight, a new hub for expert-curated quality content. The spotlight includes journal scans and expert commentaries from multiple specialty areas and is dedicated to helping you stay current and improve patient care. Membership is free, and registration takes just a moment.
The VHL Alliance is a proud partner of CURE®. CURE® is the largest consumer magazine in the United States focused entirely on cancer. Specially curated VHL content can be found here.
The VHL Alliance has partnered with Angel Flight Northeast to provide free air transportation to VHL patients who must travel outside of their geographic area for critical surgeries and other treatments. This partnership makes VHL treatment more accessible for VHL patients.
We are proud to be members of the Kidney Cancer Impact Alliance (KCIA). The Kidney Cancer Impact Alliance comprises like-minded patient, physician, and research advocates who collaborate to raise awareness, advocate and increase access for patients & caregivers impacted by kidney cancer and associated conditions. Learn more here.
We are proud to partner with the BHD Foundation, the Myrovlytis Trust, and the HLRCC.